Please don't hesitate to contact us if you have questions or comments.
Technologies offered (455)
Technologies searched (123)
Know How & Services (123)
Multisite complex enhancing vaccination against Staphylococcus aureus
New scaffolds based on a protein carrier which, as an adjuvant, increase the vaccinal efﬁcacy and neutralize simultaneously virulence ...
Bayerische Patentallianz GmbH technology transfer office of Bavarian universities
The Bayerische Patentallianz GmbH is the central patent and marketing agency of 28 Bavarian universities and universities of applied sciences and, ...
p38 alpha (Mapk14) inhibitors multiply the efficacy of Sorafenib for the treatment of hepatocellular carcinoma
The invention discloses p38 alpha (Mapk14) inhibitors as synergistic effectors, which multiply the efficacy of Sorafenib, when applied in combination.
β-L-Hydroxycytosin – a novel class of Nucleoside Analogue Reverse Transcriptase Inhibitors for the Treatment of Hepatitis B Viral Infections
In cellular assays, the compounds show up to three-fold lower IC50 values than the HBV drug Lamivudin. Cellular, including mitochondrial, ...
print this page